-
Bax Activation as Therapeutic Strategy with Cisplatin in Mucoepidermoid Carcinoma Cell lines
Korean Journal of Oral and Maxillofacial Pathology :: Vol.40 No.5 pp.839-845
DOI:https://doi.org/10.17779/KAOMP.2016.40.5.001
Open abstract
Bax Activation as Therapeutic Strategy with Cisplatin in Mucoepidermoid Carcinoma Cell lines
Korean Journal of Oral and Maxillofacial Pathology :: Vol.40 No.5 pp.839-845
DOI:https://doi.org/10.17779/KAOMP.2016.40.5.001
Open abstract
|